SCHEMBL6375289

SCHEMBL6375289

COC(c1ccccc1)C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 4/20 0.56
KDM4E B2RXH2 1/20 0.54
PKM P14618 1/20 0.54
ALDH1A1 P00352 2/20 0.49
NPC1 O15118 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
EED O75530 1/20 0.48
RBBP4 Q09028 1/20 0.48
SUZ12 Q15022 1/20 0.48
EZH2 Q15910 1/20 0.48
AEBP2 Q6ZN18 1/20 0.48
STS P08842 1/20 0.48
MMP13 P45452 6/20 0.48
MMP1 P03956 4/20 0.48
MMP3 P08254 3/20 0.47
MMP7 P09237 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417677 0.88 MMP13 (0.53) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL13591106 0.88 ALDH1A1 (0.53) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL24621773 0.85 GPR119 (0.60) GPR119KDM4EPKMALDH1A1NPC1
SCHEMBL22558670 0.84 GPR119 (0.59) GPR119KDM4EPKMALDH1A1NPC1
SCHEMBL3881476 0.84 GPR119 (0.59) GPR119KDM4EPKMALDH1A1NPC1
SCHEMBL1405370 0.84 GPR119 (0.59) GPR119KDM4EPKMALDH1A1NPC1
SCHEMBL7086566 0.84 FPR2 (0.50) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL20615705 0.83 GPR119 (0.57) GPR119KDM4EPKMALDH1A1NPC1
SCHEMBL22773361 0.83 GPR119 (0.57) GPR119KDM4EPKMALDH1A1NPC1
SCHEMBL2553057 0.83 GPR119 (0.57) GPR119KDM4EPKMALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050181988-A1 Echinocandin cyclic peptide derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050181988-A1 Echinocandin cyclic peptide derivatives NGLY1, ARG1, ERG28 GPR119 318/4885KDM4E 3740/4885PKM 2606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.